{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:07:05Z","timestamp":1793416025504,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.vaccine.2007.02.038","type":"journal-article","created":{"date-parts":[[2007,2,28]],"date-time":"2007-02-28T12:30:58Z","timestamp":1172665858000},"page":"4093-4102","source":"Crossref","is-referenced-by-count":93,"title":["A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity"],"prefix":"10.1016","volume":"25","author":[{"suffix":"Jr.","given":"Ricardo","family":"Carrion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen R.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anysha","family":"Ticer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Brasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene B.","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Moshkoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"Salvato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor S.","family":"Lukashevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7426","key":"10.1016\/j.vaccine.2007.02.038_bib1","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","article-title":"Lassa fever: epidemiology, clinical features, and social consequences","volume":"327","author":"Richmond","year":"2003","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.vaccine.2007.02.038_bib2","first-page":"86","article-title":"Update on Lassa fever in West Africa","volume":"80","author":"Anonymous","year":"2005","journal-title":"Weekly Epidemiol Rec"},{"issue":"5","key":"10.1016\/j.vaccine.2007.02.038_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3201\/eid1205.050052","article-title":"Historical Lassa fevers reports and 30-year clinical update","volume":"12","author":"Macher","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2007.02.038_bib4","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.038_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890370102","article-title":"Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys","volume":"31","author":"McCormick","year":"1992","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.038_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.02.038_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/rmv.329","article-title":"Towards a human Lassa fever vaccine","volume":"11","author":"Fisher-Hoch","year":"2001","journal-title":"Rev Med Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.038_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1586\/14760584.3.2.189","article-title":"Lassa fever vaccine","volume":"3","author":"Fisher-Hoch","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2007.02.038_bib9","series-title":"Vaccines","first-page":"1095","article-title":"Yellow fever vaccine","author":"Monath","year":"2004"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.038_bib10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0042-6822(92)90514-P","article-title":"Generation of reassortants between African arenaviruses","volume":"188","author":"Lukashevich","year":"1992","journal-title":"Virology"},{"issue":"22","key":"10.1016\/j.vaccine.2007.02.038_bib11","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1128\/JVI.79.22.13934-13942.2005","article-title":"A live-attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses","volume":"79","author":"Lukashevich","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11262-006-0050-3","article-title":"Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses","volume":"34","author":"Moshkoff","year":"2007","journal-title":"Virus Genes"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.02.038_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01310811","article-title":"Ribonucleic acids of Machupo and Lassa viruses","volume":"79","author":"Lukashevich","year":"1984","journal-title":"Arch Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.02.038_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/138920206778948673","article-title":"Lassa virus genome","volume":"7","author":"Lukashevich","year":"2006","journal-title":"Curr Genomics"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.038_bib15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1099\/0022-1317-78-3-547","article-title":"The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250kDa protein with monospecific antiserum","volume":"78","author":"Lukashevich","year":"1997","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.038_bib16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/viro.1997.8722","article-title":"Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5\u2032 end","volume":"235","author":"Djavani","year":"1997","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.038_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0042-6822(86)90438-1","article-title":"Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA","volume":"154","author":"Auperin","year":"1986","journal-title":"Virology"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2007.02.038_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0168-1702(91)90015-N","article-title":"Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products","volume":"18","author":"Clegg","year":"1991","journal-title":"Virus Res"},{"issue":"22","key":"10.1016\/j.vaccine.2007.02.038_bib19","doi-asserted-by":"crossref","first-page":"12701","DOI":"10.1073\/pnas.221447598","article-title":"The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1\/S1P","volume":"98","author":"Lenz","year":"2001","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.038_bib20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/JVI.55.3.704-709.1985","article-title":"Genetic mapping of lymphocytic choriomeningitis virus pathogenicity: virulence in guinea pigs is associated with the L RNA segment","volume":"55","author":"Riviere","year":"1985","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.038_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.virol.2006.01.026","article-title":"Phylogeny and evolution of old world arenaviruses","volume":"350","author":"Emonet","year":"2006","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.038_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.virol.2003.08.016","article-title":"New insights into the evolutionary relationships between arenaviruses provided by comparative analysis of small and large segment sequences","volume":"317","author":"Charrel","year":"2003","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.038_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/viro.2002.1695","article-title":"High genetic divergence and recombination in Arenaviruses from the Americas","volume":"304","author":"Archer","year":"2002","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.038_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/viro.2001.1127","article-title":"Reassortant analysis of guinea pig virulence of Pichinde virus variants","volume":"290","author":"Zhang","year":"2001","journal-title":"Virology"},{"issue":"16","key":"10.1016\/j.vaccine.2007.02.038_bib25","doi-asserted-by":"crossref","first-page":"8922","DOI":"10.1128\/JVI.78.16.8922-8926.2004","article-title":"Ngari virus is a bunyamwera virus reassortant that can be associated with large outbreaks of hemorrhagic fever in Africa","volume":"78","author":"Gerrard","year":"2004","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.02.038_bib26","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1128\/JVI.73.10.8196-8200.1999","article-title":"Genetic reassortment of Rift Valley fever virus in nature","volume":"73","author":"Sall","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib27","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1099\/vir.0.80121-0","article-title":"Evidence of segment reassortment in Crimean-Congo haemorrhagic fever virus","volume":"85","author":"Hewson","year":"2004","journal-title":"J Gen Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2007.02.038_bib28","doi-asserted-by":"crossref","first-page":"6992","DOI":"10.1128\/JVI.74.15.6992-7004.2000","article-title":"Genetic diversity among Lassa virus strains","volume":"74","author":"Bowen","year":"2000","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.02.038_bib29","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3201\/eid0605.000504","article-title":"Imported Lassa fever in Germany: molecular characterization of a new Lassa virus strain","volume":"6","author":"Gunther","year":"2000","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.038_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(90)90096-5","article-title":"Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine","volume":"8","author":"Saluzzo","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.038_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1099\/vir.0.81184-0","article-title":"Very virulent infectious bursal disease virus: reduced pathogenicity in a rare natural segment-B-reassorted isolate","volume":"87","author":"Le Nou\u00ebn","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib32","first-page":"5","article-title":"Experimental studies of arenaviral hemorrhagic fevers","volume":"134","author":"Peters","year":"1987","journal-title":"Curr Top Microbiol Immunol"},{"issue":"23","key":"10.1016\/j.vaccine.2007.02.038_bib33","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1128\/JVI.75.23.11677-11685.2001","article-title":"Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses","volume":"75","author":"Pushko","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib34","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1128\/JCM.32.12.2898-2903.1994","article-title":"Early diagnosis of Lassa fever by reverse transcription-PCR","volume":"32","author":"Demby","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.02.038_bib35","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00705-004-0385-9","article-title":"LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration","volume":"149","author":"Lukashevich","year":"2004","journal-title":"Arch Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.038_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jmv.1890400308","article-title":"Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen","volume":"40","author":"Lukashevich","year":"1993","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib37","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1128\/JVI.75.11.5205-5214.2001","article-title":"Ebola virus VP40-induced particle formation and association with lipid bilayer","volume":"75","author":"Jasenosky","year":"2001","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.038_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.virol.2005.12.001","article-title":"A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins","volume":"345","author":"Bredenbeek","year":"2006","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.038_bib39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1128\/IAI.37.2.771-778.1982","article-title":"Pathogenesis of Lassa virus infection in guinea pigs","volume":"37","author":"Jahrling","year":"1982","journal-title":"Infect Immun"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2007.02.038_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02122419","article-title":"Some biochemical properties of Lassa virus RNA and polypeptides","volume":"175","author":"Lukashevich","year":"1986","journal-title":"Med Microbiol Immunol (Berl)"},{"issue":"6","key":"10.1016\/j.vaccine.2007.02.038_bib41","first-page":"455","article-title":"Sedimentation analysis of the RNAs isolated from interfering particles of Lassa and Machupo viruses","volume":"29","author":"Lukashevich","year":"1985","journal-title":"Acta Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.02.038_bib42","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/JVI.78.6.3162-3169.2004","article-title":"Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus","volume":"78","author":"Asper","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib43","first-page":"75","article-title":"Lassa fever","volume":"262","author":"McCormick","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.038_bib44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0168-1702(97)01458-5","article-title":"Characterization of arenaviruses using a family-specific primer set for RT-PCR amplification and RFLP analysis. Its potential use for detection of uncharacterized arenaviruses","volume":"49","author":"Lozano","year":"1997","journal-title":"Virus Res"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.038_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/mpev.1997.0436","article-title":"Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts","volume":"8","author":"Bowen","year":"1997","journal-title":"Mol Phylogenet Evol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib46","first-page":"1","article-title":"Molecular phylogeny of the Arenaviridae","volume":"262","author":"Clegg","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.02.038_bib47","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1128\/JVI.63.10.4303-4310.1989","article-title":"Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity","volume":"63","author":"Whitton","year":"1989","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.02.038_bib48","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/eji.1830210513","article-title":"Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide","volume":"21","author":"Schulz","year":"1991","journal-title":"Eur J Immunol"},{"issue":"15","key":"10.1016\/j.vaccine.2007.02.038_bib49","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0264-410X(99)00439-9","article-title":"Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein","volume":"18","author":"Djavani","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.038_bib50","first-page":"103","article-title":"Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus","volume":"4","author":"Djavani","year":"2001","journal-title":"J Hum Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.038_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.virol.2005.01.019","article-title":"Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein","volume":"335","author":"Rodriguez-Carreno","year":"2005","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2007.02.038_bib52","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1128\/JVI.67.6.3497-3506.1993","article-title":"Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T cell clone specific for an envelope glycoprotein epitope of Lassa virus","volume":"67","author":"La Posta","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-5793(90)81140-J","article-title":"Prediction of arenavirus fusion peptides on the basis of computer analysis of envelope protein sequences","volume":"269","author":"Glushakova","year":"1990","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.038_bib54","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virol.2003.12.013","article-title":"Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T cell clones","volume":"321","author":"Meulen","year":"2004","journal-title":"Virology"},{"issue":"8552","key":"10.1016\/j.vaccine.2007.02.038_bib55","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0140-6736(87)90767-7","article-title":"Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guinea pigs against Lassa fever","volume":"2","author":"Clegg","year":"1987","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.vaccine.2007.02.038_bib56","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1128\/JVI.74.15.6777-6783.2000","article-title":"Effective vaccine for Lassa fever","volume":"74","author":"Fisher-Hoch","year":"2000","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.02.038_bib57","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1128\/JVI.74.5.2186-2192.2000","article-title":"Characterization of human CD4+ T cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein","volume":"74","author":"ter Meulen","year":"2000","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.02.038_bib58","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1128\/CDLI.12.10.1223-1230.2005","article-title":"Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice","volume":"12","author":"Boesen","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"17","key":"10.1016\/j.vaccine.2007.02.038_bib59","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.1128\/JVI.00896-06","article-title":"Identification of protective Lassa virus epitopes that are restricted by HLA-A2","volume":"80","author":"Botten","year":"2006","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.038_bib60","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1172\/JCI25608","article-title":"Peptide vaccination of mice immune to LCMV or vaccinia virus causes serious CD8+ T cell-mediated TNF-dependent immunopathology","volume":"116","author":"Liu","year":"2006","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.vaccine.2007.02.038_bib61","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4269\/ajtmh.1996.55.661","article-title":"Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea","volume":"55","author":"Ter Meulen","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.038_bib62","first-page":"131","article-title":"Activity of lymphocytic choriomeningitis virus (LCM) in the endemic area of Argentine hemorrhagic fever (AHF). Part I. Serological studies in rodents captured in the City of Pergamino","volume":"32","author":"Maiztegui","year":"1972","journal-title":"Medicina (B Aires)"},{"issue":"9520","key":"10.1016\/j.vaccine.2007.02.038_bib63","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","article-title":"Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment","volume":"367","author":"Daddario-DiCaprio","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2007.02.038_bib64","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.micinf.2006.02.002","article-title":"Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages","volume":"8","author":"Baize","year":"2006","journal-title":"Microbes Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2007.02.038_bib65","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.172.5.2861","article-title":"Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells","volume":"172","author":"Baize","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib66","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/(SICI)1096-9071(199912)59:4<552::AID-JMV21>3.0.CO;2-A","article-title":"Lassa and Mopeia virus replication in human monocytes\/macrophages and in endothelial cells: different effects on IL-8 and TNF-a gene expression","volume":"59","author":"Lukashevich","year":"1999","journal-title":"J Med Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2007.02.038_bib67","doi-asserted-by":"crossref","first-page":"10516","DOI":"10.1128\/JVI.78.19.10516-10524.2004","article-title":"Human macrophages, but not dendritic cells, are activated and produce alpha\/beta interferons in response to Mopeia virus infection","volume":"78","author":"Pannetier","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib68","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1101\/SQB.1962.027.001.046","article-title":"The biology of lymphocytic choriomeningitis virus: virus induced immune disease","volume":"27","author":"Hotchin","year":"1962","journal-title":"Coldspring Harbor Symp Quant Biol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib69","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.185.3.517","article-title":"Virus-induced transient bone marrow aplasia: Major role of interferon-alpha\/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus","volume":"185","author":"Binder","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.02.038_bib70","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature01783","article-title":"Viral infection switches non-plasmacytoid dendritic cells into high interferon producers","volume":"424","author":"Diebold","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2007.02.038_bib71","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1128\/JVI.68.3.1951-1955.1994","article-title":"Resistance of lymphocytic choriomeningitis virus to alpha\/beta interferon and to gamma interferon","volume":"68","author":"Moskophidis","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib72","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1128\/JVI.69.2.1059-1070.1995","article-title":"Destruction of virus-infected dendritic cells results in generalized immune suppression","volume":"69","author":"Borrow","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib73","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1128\/JVI.74.8.3650-3658.2000","article-title":"Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression","volume":"74","author":"Zarozinkski","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0042-6822(03)00233-2","article-title":"Protection from lethal infection is determined by innate immune responses in a mouse model of Ebola virus infection","volume":"312","author":"Mahanty","year":"2003","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2007.02.038_bib75","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1099\/0022-1317-82-6-1365","article-title":"The role of the type I interferon response in the resistance of mice to filovirus infection","volume":"82","author":"Bray","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2007.02.038_bib76","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.4049\/jimmunol.176.8.4940","article-title":"CpG ODN protect newborn mice from a lethal challenge with the neurotropic Tacaribe Arenavirus","volume":"176","author":"Pedras-Vasconcelos","year":"2006","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07001922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07001922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T07:53:11Z","timestamp":1587369191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07001922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":76,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0264410X07001922"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.02.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}